Optimization of an HCN1-selective inverse agonist for the treatment of peripheral neuropathic pain Grant uri icon

Overview

date/time interval

  • September 23, 2022 - August 31, 2027

sponsor award ID

  • 1 R42 NS129370-01

Affiliation